Optimizing Medical Pretreatment for Balloon Pulmonary Angioplasty: Overshoot or Stride Toward Optimal Multimodal Treatment

Optimizing Medical Pretreatment for Balloon Pulmonary Angioplasty: Overshoot or Stride Toward Optimal Multimodal Treatment

ABSTRACT In patients with chronic thromboembolic pulmonary hypertension (CTEPH) who undergo balloon pulmonary angioplasty (BPA), pretreatment with PH‐targeted medical therapy may be beneficial to improve clinical parameters and pulmonary hemodynamics. This study aims to describe clinical results of...

Full description

Saved in:

Bibliographic Details
Main Authors:	D. P. Staal, F. J. vanLeusden, M. C. J. vanThor, J. Peper, B. J. M. W. Rensing, J. P. vanKuijk, B. J. M. Mulder, D. van denHeuvel, K. A. Boomars, S. Boerman, J. J. Mager, M. C. Post
Format:	Article
Language:	English
Published:	Wiley 2025-01-01
Series:	Pulmonary Circulation
Subjects:	balloon pulmonary angioplasty chronic thromboembolic pulmonary hypertension pulmonary hypertension targeted medical therapy
Online Access:	https://doi.org/10.1002/pul2.70028
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

PULMONARY HYPERTENSION: DIFFICULT CASE IN CLINICAL PRACTICE
by: D. V. Madeeva, et al.
Published: (2014-07-01)

Performance of Risk‐Stratification Scores for Patients With Pulmonary Arterial Hypertension in a Multi‐Ethnic Asian Population
by: Haowen Jiang, et al.
Published: (2025-01-01)

Efficacy and safety of tadalafil in a pediatric population with pulmonary arterial hypertension: phase 3 randomized, double‐blind placebo‐controlled study
by: Dunbar Ivy, et al.
Published: (2021-07-01)

The Pulmonary Artery Pulsatility Index Provides No Additional Prognostic Information in Pediatric Pulmonary Arterial Hypertension
by: Faye E. Smits, et al.
Published: (2024-09-01)

The Epidemiology, Burden, Risk Factors, Presentations, and Challenges of Evaluating and Managing Patients with Pulmonary Hypertension in Nigeria – A Short Review
by: Oluwafemi Tunde Ojo, et al.
Published: (2024-12-01)

Balloon Pulmonary Angioplasty for the Treatment of Chronic Thromboembolic Pulmonary Hypertension
by: Lauren N. Carlozzi, et al.
Published: (2024-05-01)

EFFECTIVENESS OF ILOPROST IN PATIENTS WITH PULMONARY HYPERTENSION FC III - IV BASED ON VORONEZH REGION REGISTRY DATA
by: O. M. Korolkova, et al.
Published: (2019-06-01)

Porto-Pulmonary Hypertension and Hepato-Pulmonary Syndrome: Diagnostic Procedures and Therapeutic Management
by: Roberto G. Carbone, et al.
Published: (2025-07-01)

THE EFFICIENCY OF BOSENTAN BASED ON THE DATA OF THE REGISTER OF PATIENTS WITH PULMONARY HYPERTENSION IN THE VORONEZH REGION
by: O. M. Korolkova
Published: (2017-06-01)

The Challenge in Diagnosis and Current Treatment of Chronic Thromboembolic Pulmonary Hypertension
by: Anggoro Budi Hartopo, et al.
Published: (2017-08-01)

The Challenge in Diagnosis and Current Treatment of Chronic Thromboembolic Pulmonary Hypertension
by: Anggoro Budi Hartopo, et al.
Published: (2017-08-01)

The multidisciplinary management of pulmonary arterial hypertension patients in pregnancy and postpartum: A case series
by: Jasmine N. Edghill, et al.
Published: (2025-07-01)

Screening and management of pulmonary arterial hypertension in systemic sclerosis
by: Vivek Nagaraja, et al.
Published: (2017-01-01)

CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION: NEW ASPECTS OF THE DEVELOPMENT AND PROGRESSION OF THE DISEASE
by: A. A. Klimenko, et al.
Published: (2014-07-01)

Sarcopenia in Patients with Chronic Thromboembolic Pulmonary Hypertension
by: Steven Hopkins, et al.
Published: (2025-04-01)

Interpretation on the Guidelines for the Diagnosis and Treatment of Chronic Thromboembolic Pulmonary Hypertension(2024 edition)
by: YANG Furong, et al.
Published: (2025-05-01)

Soluble Guanylate Cyclase Stimulators for Chronic Thromboembolic Pulmonary Hypertension Patients Treatment: New Data
by: M. A. Simakova, et al.
Published: (2020-05-01)

Clinicolaboratory characteristics and 1-year survival among group 1 pulmonary hypertension in a university hospital
by: Mostafa K. Ahmed, et al.
Published: (2024-12-01)

Similar quality of life after balloon pulmonary angioplasty or pulmonary endarterectomy for CTEPH
by: P. Smeele, MD, et al.
Published: (2025-05-01)

Pulmonary thromboendarterectomy in pediatric patients: Report of three cases
by: Ulaş Kumbasar, et al.
Published: (2018-10-01)

Revisiting hemodynamic definition: Incidence of chronic thromboembolic pulmonary hypertension following acute intermediate-high and high-risk pulmonary embolism
by: Bárbara Lacerda Teixeira, et al.
Published: (2024-12-01)

Multicentre, randomised controlled trial of physiological-based cord clamping versus immediate cord clamping in infants with a congenital diaphragmatic hernia (PinC): statistical analysis plan
by: Emily J. J. Horn-Oudshoorn, et al.
Published: (2024-03-01)

OPPORTUNITIES FOR OPTIMIZATION OF DRUG THERAPY BY ENDOTHELIN RECEPTOR ANTAGONISTS FOR THE PATIENT WITH IDIOPATHIC PULMONARY ARTERIAL HYPERTENSION AND ATRIAL SEPTOSTOMY
by: V. V. Gramovich, et al.
Published: (2018-12-01)

CASE REPORT ON THE SUCCESSFUL USE OF A NEW SELECTIVE PROSTACYCLIN IP RECEPTOR AGONIST, SELEXIPAG, IN A PATIENT WITH IDIOPATHIC PULMONARY HYPERTENSION
by: Z. S. Valieva, et al.
Published: (2019-12-01)

CLINICAL CASE OF REPLACEMENT OF ENDOTHELIN RECEPTOR ANTAGONIST (BOSENTAN) BY SOLUBLE GUANYLATE CYCLASE STIMULATOR (RIOCIGUAT) IN THE PATIENT WITH PULMONARY ARTERIAL HYPERTENSION
by: E. A. Devetyarova, et al.
Published: (2018-06-01)

THE ROLE OF RADIATION DIAGNOSTIC TECHNIQUES IN THE DIAGNOSIS OF CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION
by: E. A. Mershina, et al.
Published: (2016-07-01)

Statistical modeling to determine severity of respiratory sarcoidosis and parameters associated with cardiac sarcoidosis: as a way to stratify the risk of developing pulmonary hypertension
by: T. P. Kalacheva, et al.
Published: (2025-04-01)

CLINICAL CASE: CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION IN A CHILD
by: D. J. Sadykova, et al.
Published: (2017-03-01)

LEFT MAIN CORONARY ARTERY COMPRESSION SYNDROME IN PATIENT WITH PULMONARY ARTERIAL HYPERTENSION. FIRST CLINICAL EXPERIENCE
by: A. N. Bykov, et al.
Published: (2018-12-01)

EURASIAN ASSOCIATION OF CARDIOLOGY (EAC) GUIDELINES FOR THE DIAGNOSIS AND TREATMENT OF CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION (2020)
by: I. E. Chazova, et al.
Published: (2021-03-01)

The pulmonary resistance‐compliance relationship: Real or mathematical artifact?
by: Sara Hungerford, et al.
Published: (2025-05-01)

How to Assess Pulmonary Circulation and Right Heart Chambers in Systemic Sclerosis Patients?
by: Michele Correale, et al.
Published: (2025-04-01)

EFFICACY AND SAFETY OF INHALED NITRIC OXIDE USE IN PATIENTS WITH PULMONARY HYPERTENSION AND CHRONIC HEART FAILURE III-IV FUNCTIONAL CLASS, SURVIVED LEFT VENTRICULAR MYOCARDIAL INFARCTION: RESULTS OF NON-RANDOMIZED COMAPARIVE STUDY
by: P. N. Pavlenko, et al.
Published: (2014-07-01)

Disparities in Clinical Outcomes Observed Within Electronic Health Record Data From a Statewide Cohort of Pulmonary Arterial Hypertension Patients
by: Rachel Dalton, et al.
Published: (2025-01-01)

Beyond the inhaled nitric oxide in persistent pulmonary hypertension of the newborn
by: Mei-Yin Lai, et al.
Published: (2018-02-01)

DIAGNOSTIC SPECIFICS OF PULMONARY VENO-OCCLUSIVE DISEASE
by: E. A. Zhuk, et al.
Published: (2012-06-01)

Balloon pulmonary angioplasty in patients with chronic thromboembolic pulmonary hypertension: short- and long-term results from a cohort in Brazil
by: Fabio Solano de Freitas Souza, et al.
Published: (2025-01-01)

Introducing Historical Vignettes in Pulmonary Circulation
by: Harold I. Palevsky, et al.
Published: (2025-01-01)

Pulmonary artery pseudoaneurysm in a young man with pulmonary hypertension on computed tomography angiography
by: Tairkhan B. Dautov, et al.
Published: (2024-12-01)

A clinical case of radiofrequency pulmonary artery denervation for treatment of a patient with residual chronic thromboembolic pulmonary hypertension
by: D. A. Feshchenko, et al.
Published: (2019-12-01)